ArticleClinical case reports2025
Incidentally Discovered Ovarian Cancer Combined With Obturator Nerve Schwannoma: A Rare Case Report.
Article in Clinical case reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Incidentally Discovered Ovarian Cancer Combined With Obturator Nerve Schwannoma: A Rare Case Report.Clinical case reports · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
A rare coexistence of high-grade serous ovarian cancer and an obturator nerve schwannoma presented as a node-like pelvic sidewall mass. A 50-year-old woman had progressive abdominal distension, CA-125 1534 U/mL (reference range 0-35 U/mL), and computed tomography (CT) showing ovarian cancer with a left sidewall mass interpreted as nodal disease. After three cycles of paclitaxel-carboplatin, the ovarian disease regressed while the sidewall mass was unchanged. Because a percutaneous route was likely to traverse major vessels and open cytoreduction was planned, biopsy was deferred. At laparotomy, a well-circumscribed lesion centered on the obturator canal was dissected along the epineurial plane and intracapsularly enucleated, preserving the obturator nerve and its fascicles. Pathology showed schwannoma (spindle-cell fascicles with Verocay bodies; diffuse S-100 positivity; no epithelial markers). Posttreatment CT met the Response Evaluation Criteria in Solid Tumors (RECIST) 1.1 for complete response; the patient received maintenance olaparib plus bevacizumab and, at 32-month follow-up, had no evidence of recurrence with intact adductor function. This case suggests that, during ovarian cancer cytoreduction, a stable, well-circumscribed sidewall mass on CT-particularly along the obturator canal-should raise suspicion for a neurogenic tumor; when biopsy access is unsafe and open surgery is planned, nerve-sparing enucleation is an appropriate management option.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.